Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. The global response to the COVID-19 pandemic was beset with several challenges, but one bright spot stood out: the whole vaccine research and development pipeline was accomplished in just under 300 days, an unprecedented timeline.
    Published: June 2023
  2. The COVID-19 pandemic highlighted the urgent need to scale up medical oxygen systems. In Kenya, oxygen availability varies depending on the location and facility. PATH’s Lisa Smith spoke with Nation about how to increase access to medical oxygen.
    Published: June 2023
  3. A new meningitis vaccine, developed by PATH and the Serum Institute of India, has shown promise in the fight against the disease, eliciting immune responses against five main strains.
    Published: May 2023
  4. With support from Gavi, the Vaccine Alliance, PATH, WHO, and other partners, the government of Malawi launched an integrated vaccine campaign to deliver measles-rubella vaccines and typhoid conjugate vaccine (TCV).
    Published: May 2023

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

971 Item s
971 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release